AIDS drug trials attackedBMJ 1997; 314 doi: https://doi.org/10.1136/bmj.314.7089.1217i (Published 26 April 1997) Cite this as: BMJ 1997;314:1217
- Jacqui Wise
The design of clinical trials for AIDS drug treatments have been sharply criticised by an AIDS researcher.
Joep Lange, from the national AIDS therapy evaluation centre in Amsterdam, says that too often suboptimal drug treatments are still being used, both in the treatment of patients with AIDS and in clinical trials (Science 1997;276:548-50). This is partly because regulatory requirements often dictate …